Related Experiment Video

Updated: Jun 25, 2026

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
08:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 18, 2011

Management of early-onset breast cancer and BRCA1 or BRCA2 status

Jayant S Vaidya, Michael Baum

    Lancet (London, England)
    |September 21, 2002
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
    13:04

    In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

    Published on: October 14, 2015

    Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
    09:24

    Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

    Published on: August 12, 2015

    Related Experiment Videos

    Last Updated: Jun 25, 2026

    Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
    08:53

    Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

    Published on: February 18, 2011

    In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
    13:04

    In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

    Published on: October 14, 2015

    Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
    09:24

    Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

    Published on: August 12, 2015

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...
    Cancer Survival Analysis01:21

    Cancer Survival Analysis

    Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

    Articles linked to this work by shared authors, journal, and citation graph.

    Rhizosphere Microbiome Engineering for Climate-Smart Agriculture: From Synthetic Consortia to Precision Decision Support.

    Microorganisms·2026

    Effect of COVID-19 NHS breast screening pause on breast cancer presentation and management: an insight into overdiagnosis.

    JRSM open·2026

    A novel methodology using direct patient contact and UK national registries to collect long-term data from randomised trials: TARGIT-X - an extended follow-up study of the TARGIT-A trial of targeted intraoperative radiotherapy for breast cancer.

    Health technology assessment (Winchester, England)·2026

    Design and development of a portable multiwavelength LED-based diffuse reflectance spectroscopy tool for rapid breast cancer identification.

    Scientific reports·2025

    Whole-genome resequencing of the wild barley diversity collection: a resource for identifying and exploiting genetic variation for cultivated barley improvement.

    G3 (Bethesda, Md.)·2025

    Menopausal hormone therapy for breast cancer patients: what is the current evidence?

    Menopause (New York, N.Y.)·2025

    8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

    Lancet (London, England)·2026

    Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

    Lancet (London, England)·2026

    A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

    Lancet (London, England)·2026

    Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

    Lancet (London, England)·2026

    Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

    Lancet (London, England)·2026

    Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

    Lancet (London, England)·2026

    The causal integration ladder: a multilevel evidence framework for therapeutic target evaluation in cervical cancer.

    Frontiers in systems biology·2026

    Exploring beyond the typical Wilms tumor: What a radiologist needs to know.

    Current problems in diagnostic radiology·2026

    Choosing Wisely, Using Wisely: Diagnostics, Defining the Disease Stage, and Deciding about Breast Cancer Treatment.

    Southern medical journal·2026

    Concordance of p16 status between US-guided core needle biopsy and surgical specimens in oropharyngeal squamous cell carcinoma: A diagnostic accuracy study.

    Medicine·2026

    Usefulness of 18F-fluorodeoxyglucose positron emission tomography for T1 esophageal squamous cell carcinoma.

    Medicine·2026

    Biopsy Type and Metastatic Recurrence in Melanoma: A Cohort Study.

    Journal of drugs in dermatology : JDD·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us